Drug application
UNASYN (AMPICILLIN SODIUM, SULBACTAM SODIUM)
Drugs@FDA NDA 050608 · PFIZER
Key facts
| Drug name | UNASYN |
|---|---|
| Active ingredients | AMPICILLIN SODIUM, SULBACTAM SODIUM |
| Application type | NDA |
| Application number | 050608 |
| Company | PFIZER |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity and Type 4 - New Combination |
| Latest submission status date | Dec 31, 1986 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: